Qualigen therapeutics, inc. received nasdaq notice of a delisting determination

Carlsbad, calif., may 30, 2024 (globe newswire) -- qualigen therapeutics, inc. (“qualigen” or “the company,” nasdaq: qlgn), announced today that on may 23, 2024, it received written notice (the “delist notice”) from the nasdaq stock market (“nasdaq”) indicating the company's continued non-compliance with the minimum bid price requirement, pursuant to listing rule 5550(b)(2).
QLGN Ratings Summary
QLGN Quant Ranking